Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Sep 22, 2016
Insider Transaction Report
Form 4
MCCABE JOHN J
Senior Vice President, Finance
Transactions
- Award
Stock Option (Right to Buy)
2016-09-20+100,000→ 100,000 totalExercise: $3.37Exp: 2026-09-19→ Common Stock (100,000 underlying) - Award
Stock Option (Right to Buy)
2016-09-20+6,664→ 20,000 totalExercise: $0.28From: 2016-09-20Exp: 2026-02-24→ Common Stock (6,664 underlying)
Footnotes (2)
- [F1]On February 25, 2016, the reporting person was granted an option to purchase 20,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 6,664 shares. The option had previously vested with respect to 13,336 shares.
- [F2]25% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option.